Gary Shangold MD is a board-certified Obstetrician/Gynecologist and Reproductive Endocrinologist who is newly-appointed as Chief Medical Officer for Biodexa Pharmaceuticals PLC. His career in the pharmaceutical industry spans more than 30 years, including senior positions in Clinical Research, Product Development, Regulatory Affairs, and general management. He has played key roles in the development and/or registration of more than ten approved products, including having led the team at Johnson & Johnson which developed the world’s first transdermal contraceptive patch. Before joining the pharma industry, Dr. Shangold spent a decade in academia, on the faculty of The University of Chicago Pritzker School of Medicine, and then later at the Massachusetts General Hospital and the Harvard School of Medicine. He has previously served as President of the American Academy of Pharmaceutical Physicians, and as Chair of the Association of Clinical Research Professionals, a 14,000-member nonprofit dedicated to excellence and professionalism in clinical research globally.